Home - Products - Others - Other Targets - Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)

Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)

CAS No. 429619-37-4

Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)( ——— )

Catalog No. M40406 CAS No. 429619-37-4

Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge D-Cys2-Cys8)
  • Note
    Research use only, not for human use.
  • Brief Description
    Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8)
  • Description
    Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    429619-37-4
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • δ-Valerolactone

    δ-Valerolactone is a compound commonly used to synthesize copolyesters by means of lipase-catalyzed ring-opening polymerization.

  • 7-Methyl-6-mercaptop...

    7-Methyl-6-mercaptopurine is an inhibitor of PRPP aminotransferase, inhibits IMP metabolism and prevents purine, DNA and RNA synthesis.

  • Ipivivint

    Ipivivint (Compound 38) is an orally active and potent CDC-like kinase (CLK) inhibitor with EC50s of 1 nM, 7 nM for CLK2 and CLK3, respectively. Ipivivint inhibits Wnt pathway (EC50=13 nM).